• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

ZX-29

CAS No. 2254805-62-2

ZX-29 ( —— )

产品货号. M26525 CAS No. 2254805-62-2

ZX-29 是一种有效的选择性 ALK 抑制剂,还可诱导保护性自噬并具有抗肿瘤作用。

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
5MG ¥2071 有现货
10MG ¥3297 有现货
25MG ¥5143 有现货
50MG ¥7003 有现货
100MG ¥8883 有现货
200MG ¥12330 有现货
500MG 获取报价 有现货
1G 获取报价 有现货
1 mL x 10 mM in DMSO ¥2366 有现货

生物学信息

  • 产品名称
    ZX-29
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    ZX-29 是一种有效的选择性 ALK 抑制剂,还可诱导保护性自噬并具有抗肿瘤作用。
  • 产品描述
    ZX-29 is a potent and selective inhibitor of ALK(IC50 of 2.1 nM, 1.3 nM and 3.9 nM for ALK, ALK L1196M and ALK G1202R mutations, respectively), and also induces protective autophagy and has antitumor effect.(In Vitro):ZX-29 dose-dependently inhibits colony formation of NCI-H2228 cells. With an increase in ZX-29 concentration, the cell density decreased gradually, and the cells lost their normal morphology and become sharp and slender. In NCI-H2228 cells, ZX-29 (10 nM; 0-48 hours) inhibits the proliferation of and arrests the cells in G1 phase. ZX-29 (0-81 nM; 24-72 hours) treatment resulted in a decrease in the viability with time and dose. ZX-29 (10 nM; 24 hours) treatment causes typical signs of autophagy and the formation of autophagosomes and enhances the expression level of LC3 and Beclin1. ZX-29 (20 nM; 0-48 hours) treatment significantly increases the mRNA level of CHOP. (In Vivo):In a mouse xenograft model, ZX-29 treatment suppresses tumor growth.
  • 体外实验
    ZX-29 (0-81 nM; 24-72 hours; NCI-H2228 cells) treatment leads to a time- and dose-dependent decrease in NCI-H2228 cell viability.ZX-29 (10 nM; 24 hours; NCI-H2228 cells) treatment causes typical signs of autophagy and the formation of autophagosomes. ZX-29 enhances the expression level of LC3 and Beclin1.ZX-29 (10 nM; 0-48 hours; NCI-H2228 cells) inhibits the proliferation of NCI-H2228 cells and arrests the cells in G1 phase.ZX-29 (10-40 nM; 24-48 hours; NCI-H2228 cells) treatment induces apoptosis of NCI-H2228 cells. ZX-29 dose-dependently upregulates the expression levels of proapoptotic protein Bax, increases the production of activated forms of caspase 3, and downregulates the expression level of antiapoptotic protein Bcl-2.ZX-29 (30-300 nM; 24 hours; NCI-H2228 cells) treatment significantly down-regulates the expression of p-ALK and its downstream signaling proteins, including p-Akt and p-STAT3, in a dose-dependent manner.ZX-29 (20 nM; 0-48 hours; NCI-H2228 cells) treatment significantly increases the mRNA level of CHOP.ZX-29 dose-dependently inhibits colony formation of NCI-H2228 cells. With an increase in ZX-29 concentration, the cell density decreased gradually, and the cells lost their normal morphology and become sharp and slender. Cell Viability Assay Cell Line:NCI-H2228 cells Concentration:0 nM, 1 nM, 3 nM, 9 nM, 10 nM, 27 nM or 81 nM Incubation Time:24 hours, 48 hours or 72 hours Result:Led to a time- and dose-dependent decrease in NCI-H2228 cell viability. Cell Autophagy Assay Cell Line:NCI-H2228 cells Concentration:10 nM Incubation Time:24 hours Result:Caused typical signs of autophagy and the formation of autophagosomes.Cell Cycle Analysis Cell Line:NCI-H2228 cells Concentration:0 hour, 12 hours, 24 hours or 48 hours Incubation Time:24 hours Result:Arrested the NCI-H2228 cells in G1 phase in a time-dependent manner.Apoptosis Analysis Cell Line:NCI-H2228 cells Concentration:10 nM, 20 nM or 40 nM Incubation Time:24 hours, 48 hours Result:Promoted NCI-H2228 cell apoptosis in a dose-dependent manner.Western Blot AnalysisCell Line:NCI-H2228 cells Concentration:30 nM, 100 nM, 300 nM Incubation Time:24 hours Result:Significantly down-regulated the expression of p-ALK and its downstream signaling proteins, including p-Akt and p-STAT3, in a dose-dependent manner. RT-PCRCell Line:NCI-H2228 cells Concentration:20 nM Incubation Time:0 hour, 6 hours, 12 hours, 24 hours or 48 hoursResult:The mRNA level of CHOP was increased significantly.
  • 体内实验
    ZX-29 (50 mg/kg; intragastric administration; every 2 days; for a total of 7 times; female BALB/c nude mice) treatment suppresses tumor growth in a mouse xenograft model. Animal Model:Female BALB/c nude mice (4-week-old) with H2228 cells Dosage:50 mg/kg Administration:Intragastric administration; every 2 days; for a total of 7 times Result:Showed significantly attenuated tumor growth.
  • 同义词
    ——
  • 通路
    Angiogenesis
  • 靶点
    ALK
  • 受体
    Dnm1 GTPase
  • 研究领域
    ——
  • 适应症
    ——

化学信息

  • CAS Number
    2254805-62-2
  • 分子量
    518.03
  • 分子式
    C23H28ClN7O3S
  • 纯度
    >98% (HPLC)
  • 溶解度
    In Vitro:?DMSO : 50 mg/mL (96.52 mM)
  • SMILES
    COc1cc(ccc1Nc1ncc(Cl)c(Nc2ccccc2NS(C)(=O)=O)n1)N1CCN(C)CC1
  • 化学全称
    ——

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1.N. Gorski, et al. Mixtures of Nonionic and Ionic Surfactants. The Effect of Counterion Binding in Mixtures of Tetradecyldimethylamine Oxide and Tetradecyltrimethylammonium Bromide. Langmuir 1994, 10, 8, 2594-2603.
产品手册
关联产品
  • Blu-782

    Blu-782 是一种激活素受体样激酶 2 (ALK2) 抑制剂(IC50 <10 nM)。

  • JH-VIII-157-02

    JH-VIII-157-02 是一种有效的、口服活性的、中枢神经系统可渗透的第二代 ALK G1202R 突变体抑制剂,IC50 为 2 nM。

  • ALK-IN-27

    ALK-IN-27 (compound 1) 是一种有效的 ALK 抑制剂。ALK-IN-27 显示出抗肿瘤活性。对于 Ba/F3 CLIP1-LTK 细胞,ALK-IN-27 的 IC50 为 2.7 nM。